|
SMC3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.215750E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.945600E-01 |
| Normal-vs-Stage2 |
8.323600E-02 |
| Normal-vs-Stage3 |
2.32909999999809E-05 |
| Normal-vs-Stage4 |
5.033100E-04 |
| Stage1-vs-Stage2 |
2.565800E-01 |
| Stage1-vs-Stage3 |
7.90489999999977E-05 |
| Stage1-vs-Stage4 |
3.636500E-03 |
| Stage2-vs-Stage3 |
2.319800E-01 |
| Stage2-vs-Stage4 |
4.134000E-01 |
| Stage3-vs-Stage4 |
6.097600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.965730E-02 |
| Normal-vs-AfricanAmerican |
2.903300E-03 |
| Normal-vs-Asian |
8.086200E-01 |
| Caucasian-vs-AfricanAmerican |
1.987810E-01 |
| Caucasian-vs-Asian |
5.485800E-01 |
| AfricanAmerican-vs-Asian |
2.690800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.277500E-03 |
| Normal-vs-Female |
1.330010E-01 |
| Male-vs-Female |
6.698200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.019800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.648300E-02 |
| Normal-vs-Age(61-80Yrs) |
5.175800E-03 |
| Normal-vs-Age(81-100Yrs) |
8.46330000000561E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.998800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.230000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.394500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.019200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.412140E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.542130E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.578300E-02 |
| Normal-vs-Grade 2 |
5.383200E-01 |
| Normal-vs-Grade 3 |
2.13099999999411E-05 |
| Normal-vs-Grade 4 |
1.97114999999082E-05 |
| Grade 1-vs-Grade 2 |
4.410300E-02 |
| Grade 1-vs-Grade 3 |
1.64768999999509E-05 |
| Grade 1-vs-Grade 4 |
2.15459999999279E-05 |
| Grade 2-vs-Grade 3 |
4.14329999998131E-06 |
| Grade 2-vs-Grade 4 |
6.18119999999944E-05 |
| Grade 3-vs-Grade 4 |
1.982790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.406400E-01 |
| Normal-vs-ccB subtype |
3.64910000000274E-05 |
| ccA subtype-vs-ccB subtype |
2.94349999929722E-09 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.806470E-02 |
| Normal-vs-N1 |
5.789600E-02 |
| N0-vs-N1 |
5.759800E-01 |
|
|
